R Landin

Summary

Affiliation: Parke-Davis Pharmaceutical Research
Country: USA

Publications

  1. ncbi The impact of restrictive entry criterion during the placebo lead-in period
    R Landin
    Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Biometrics 56:271-8. 2000

Detail Information

Publications1

  1. ncbi The impact of restrictive entry criterion during the placebo lead-in period
    R Landin
    Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Biometrics 56:271-8. 2000
    ..This presentation investigates the effectiveness of a restrictive entry criterion and proposes an alternative explanation for what is usually defined as placebo response...